
Reset all filters
01 11Nplate
02 8Romiplate
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 850
2019 Revenue in Millions : 795
Growth (%) : 7
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 1,027
2020 Revenue in Millions : 850
Growth (%) : 21
Main Therapeutic Indication : Hematology
Currency : USD
2020 Revenue in Millions : 72
2019 Revenue in Millions : 46
Growth (%) : 55
Main Therapeutic Indication : Hematology
Currency : USD
2021 Revenue in Millions : 62
2020 Revenue in Millions : 72
Growth (%) : -4
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 79
2021 Revenue in Millions : 62
Growth (%) : 28
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 1,307
2021 Revenue in Millions : 1,027
Growth (%) : 27
Main Therapeutic Indication : Hematology
Currency : USD
2023 Revenue in Millions : 81
2022 Revenue in Millions : 79
Growth (%) : 15
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 1,477
2022 Revenue in Millions : 1,307
Growth (%) : 13
Main Therapeutic Indication : Hematology
Currency : USD
2024 Revenue in Millions : 91
2023 Revenue in Millions : 81
Growth (%) : 12
Main Therapeutic Indication : Immunology
Currency : USD
2024 Revenue in Millions : 1,456
2023 Revenue in Millions : 1,477
Growth (%) : -1